Ponente: Dra. María Victoria Arévalo Prieto, Ph.D

Doctorado en Ciencias Sociales con Mención en Psicología: Universidad de Radboud, Nimega Holanda. Posgrado en Terapia Conductual Cognitiva Universidad Libre-Berlín Alemania. Diploma de Honor otorgado por el Colegio de Psicólogos del Perú (2003). Directora del Instituto Peruano de Terapia Cognitivo Conductual con Especialización en Terapia Conductual Cognitiva Basada en la Evidencia

Stimulants are a class of drugs that act on the central nervous system, increasing alertness, energy, and attention while elevating mood. They achieve these effects by enhancing the activity of neurotransmitters such as dopamine and norepinephrine in the brain.

Many stimulant-related hazards are linked to intensive, high-dose, or long-term usage. The mode of administration plays a significant moderating role; injecting stimulants and smoking crack cocaine or methamphetamine have been specifically associated with more problematic use behaviours. Even people who use stimulants sporadically or...

In a world where substance use continues to pose a significant threat to health and well-being, Kenya is taking a bold stand. Kenya hosted the first National Prevention Week 2024 culminating in the National Substance Use Prevention Summit 2024.

This was not just an event but a powerful statement of intent that drug use prevention works. Under the theme, “Our Families, Our Schools. Our Workplaces. Our Community: A Sustainable Future for Humanity”, this inaugural initiative was a rallying call for action, education, and unity in the campaign against substance use and abuse in Kenya. It was an...

The Vienna & New York NGO Committees on Drugs are pleased to present the global civil society report for the 2024 mid-term review of the Commission on Narcotic Drugs (CND).
The report is the result of constructive inputs by more than 200 NGOs from all regions of the world, representing a wide range of expertise and perspectives on drug-related issues. It showcases the importance of meaningful civil society engagement in the formulation and implementation of drug policies on all levels, as well as the challenges and opportunities that civil society faces in this regard.

The report reflects the...